In fact, all GLP-1 receptor agonists have some risk of gastrointestinal side effects namely, nausea, vomiting, diarrhea, and constipation due to how they work in the body
Its main competitor, Eli Lilly and Company, is gearing up for an FDA decision on its own GLP-1 pill, orforglipron, sometime in the second quarter
By hitting all three targets, Retatrutide creates a combined effect that single-receptor treatments cannot match
a few can drift the wrong way, especially if nausea cuts your food and fluid intake or you lose weight quickly
Around 70% of women with PCOS experience insulin resistance, which plays a significant role in disrupted ovulation
You know, when you have a poor blood sugar control, it also amplifies pain sensitivity